07 June 2023: Database Analysis
Database Analysis
Bin Zhu 1AE* , MingNan Cao 1BF* , Qiao Wu 2BC , Kejia Liu 3BC , Wei Guo 4AD* , Zhigang Zhao 1AD*DOI: 10.12659/MSM.939546
Med Sci Monit 2023; 29:e939546
Table 1 Demographic characteristics of participants with hyperuricemia and without hyperuricemia in the study.
| Characteristics | TotalN=3540 | No Hyperuricemian=2939 | Hyperuricemian=601 | P value |
|---|---|---|---|---|
| 40–49 years | 1095 (30.9%) | 961 (32.7%) | 134 (22.3%) | |
| 50–59 years | 960 (27.1%) | 812 (27.6%) | 148 (24.6%) | |
| 60–69 years | 854 (24.1%) | 678 (23.1%) | 176 (29.3%) | |
| ≥70 years | 631 (17.8%) | 488 (16.6%) | 143 (23.8%) | |
| 0.092 | ||||
| Male | 1639 (46.3%) | 1342 (45.7%) | 297 (49.4%) | |
| Female | 1901 (53.7%) | 1597 (54.3%) | 304 (50.6%) | |
| Hispanic American | 918 (25.9%) | 786 (26.7%) | 132 (22.0%) | |
| Non-Hispanic American | 1295 (36.6%) | 1084 (36.9%) | 211 (35.1%) | |
| Black | 777 (21.9%) | 592 (20.1%) | 185 (30.8%) | |
| Other | 550 (15.5%) | 477 (16.2%) | 73 (12.1%) | |
| 0.008 | ||||
| Never | 1968 (55.6%) | 1651 (56.2%) | 317 (52.7%) | |
| Past | 933 (26.4%) | 745 (25.3%) | 188 (31.3%) | |
| Current | 639 (18.1%) | 543 (18.5%) | 96 (16.0%) | |
| 0.102 | ||||
| No | 3082 (87.1%) | 2571 (87.5%) | 511 (85.0%) | |
| Yes | 458 (12.9%) | 368 (12.5%) | 90 (15.0%) | |
| 0.001 | ||||
| No | 1971 (55.7%) | 1601 (54.5%) | 370 (61.6%) | |
| Yes | 1569 (44.3%) | 1338 (45.5%) | 231 (38.4%) | |
| No | 2735 (77.3%) | 2324 (79.1%) | 411 (68.4%) | |
| Yes | 805 (22.7%) | 615 (20.9%) | 190 (31.6%) | |
| n (%) for categorical variables; the value was calculated by the weighted chi-square test. | ||||